Category: Vaccines
Global Vaccines
-
Global Human Vaccines Competitive Landscape Professional Research Report 2024
... typically contain weakened or inactivated forms of pathogens, or components of pathogens, which prompt the body to produce an immune response without causing the actual disease. When a person is vaccinated, their immune system learns ... Read More
-
Global Swine Vaccines Competitive Landscape Professional Research Report 2024
... system to produce antibodies against specific pathogens, thereby preventing or reducing the severity of illnesses. Swine vaccines are crucial in the agricultural industry to maintain herd health, improve animal welfare, and prevent economic losses due ... Read More
-
Global DPT Vaccines Competitive Landscape Professional Research Report 2024
... These vaccines are typically given as a series of shots to infants and young children, followed by booster doses during adolescence and adulthood to ensure continued immunity. Diphtheria can lead to severe respiratory and heart ... Read More
-
Global mRNA Vaccines and Therapeutics Competitive Landscape Professional Research Report 2024
... RNA to instruct cells in the body to produce specific proteins or trigger immune responses. In the context of vaccines, mRNA vaccines have gained significant attention for their role in protecting against infectious diseases, such ... Read More
-
Global Cell Culture Media for Vaccine Competitive Landscape Professional Research Report 2024
... the manufacturing process of vaccines. These media are designed to support the growth of specific cell lines, such as mammalian cells, insect cells, or avian cells, which are used as hosts for viral replication or ... Read More
-
Global Poultry Vaccines Competitive Landscape Professional Research Report 2024
... in preventing and controlling the spread of various viral, bacterial, and parasitic diseases that can adversely impact poultry health and production. Poultry vaccines are administered through various methods, including injection, drinking water, or spray applications. ... Read More
-
Global Avian Influenza Vaccines Competitive Landscape Professional Research Report 2024
... used as a part of disease control measures, especially in situations where there is an outbreak of avian influenza. The vaccine works by stimulating the immune system of the bird, so that it produces a ... Read More
-
Ebola Virus Vaccine Market (Vaccine Type: cAd3-ZEBOV and rVSV-ZEBOV; and Route of Administration: Oral and Intravenous) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... TMR’s report on the global Ebola virus vaccine market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period ... Read More
-
Cholera Vaccines Market by Type (Inactivated Vaccine, Live Attenuated Vaccine), Method of Administration (Injectable Vaccines, Oral Vaccines), End User, Age Group - Global Forecast 2024-2030
... million in 2023 and expected to reach USD 307.02 million in 2024, at a CAGR 7.32% to reach USD 469.83 million by 2030. Cholera vaccines are biological preparations designed to protect individuals from cholera, a ... Read More
-
Vaccine Contract Manufacturing Market by Type (Attenuated Vaccine, DNA Vaccines, Inactivated Vaccine), Function (Downstream, Upstream), Application - Global Forecast 2024-2030
... expected to reach USD 5.51 billion in 2024, at a CAGR 9.21% to reach USD 9.39 billion by 2030. Vaccine contract manufacturing refers to outsourcing vaccine production processes to third-party organizations, known as contract manufacturing ... Read More
-
Porcine Vaccines Market by Indication (Arthritis, Diarrhea, Porcine Circovirus Associated Disease), Technology (Conjugate Vaccines, DNA Vaccines, Inactivated Vaccines), End User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 1.82 billion in 2024, at a CAGR 6.72% to reach USD 2.70 billion by 2030. Porcine vaccines are immunological preparations designed to prevent various swine diseases in pigs. ... Read More
-
Veterinary Vaccines Market by Animal Type (Aquaculture, Companion Animals, Livestock), Technology (Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines), Route of Administration, Distribution Channel - Global Forecast 2024-2030
... USD 9.82 billion in 2023 and expected to reach USD 10.40 billion in 2024, at a CAGR 6.43% to reach USD 15.19 billion by 2030. Veterinary vaccines are biologically prepared substances that stimulate an animal's ... Read More
-
Vaccine Adjuvants Market by Product (Adjuvant Emulsions, Combination Adjuvants, Mineral Adjuvants), Route of Administration (Intradermal, Intramuscular, Intranasal), Disease, Application - Global Forecast 2024-2030
... 2023 and expected to reach USD 884.18 million in 2024, at a CAGR 7.88% to reach USD 1,404.20 million by 2030. Vaccine adjuvants are essential components in the formulation of vaccines, which enhance and modulate ... Read More
-
Travel Vaccines Market by Type (Attenuated Vaccines, Conjugate Vaccines, DNA Vaccines), Disease (DPT, Hepatitis A, Hepatitis B) - Global Forecast 2024-2030
... expected to reach USD 9.09 billion in 2024, at a CAGR 10.06% to reach USD 16.18 billion by 2030. The travel vaccines market encompasses the production, distribution, and administration of immunizations recommended or required for ... Read More
-
Pneumococcal Vaccine Market by Type (Conjugate Vaccines, Polysaccharide Vaccines), Indication (Bronchitis, Meningitis, Pneumonia), Age Group, Distribution - Global Forecast 2024-2030
... to reach USD 11.56 billion in 2024, at a CAGR 7.92% to reach USD 18.30 billion by 2030. The pneumococcal vaccine is designed to protect against infections caused by the streptococcus pneumoniae bacteria. These infections ... Read More
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Global Forecast 2024-2030
... USD 55.66 billion in 2023 and expected to reach USD 59.94 billion in 2024, at a CAGR 7.79% to reach USD 94.14 billion by 2030. Vaccines are biological preparations that equip the body's immune system ... Read More
-
Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2024-2030
... at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030. Foot and mouth disease vaccines are biologics designed to ... Read More
-
Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)
... demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure ... Read More
-
Global AAV Contract Development and Manufacturing Organizations Market Size Study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User and Regional Forecasts 2022-2032
... End-User and Regional Forecasts 2022-2032 Global AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 621 million in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Messenger RNA (mRNA)-based Vaccines and Therapeutics – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, ... Read More
-
Hepatitis B Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 8.38 billion in 2023, and the market is now projected to grow from to USD 8.85 billion in 2024 to USD 13.31 billion by 2032, exhibiting a CAGR of 5.2% during the ... Read More
-
Global Continuous Bioprocessing Market Size study & Forecast, by Product (Filtration Systems and Consumables, Chromatography Systems and Consumables, Bioreactors, Sterilizers, Centrifuges, Others), by Application (Commercial, Vaccines, mAb production, Recombinant Protein Production, Cell and Gene Therapy Production, R&D), by End User and Regional Analysis, 2023-2030
... Production, R&D), by End User and Regional Analysis, 2023-2030 Global Continuous Bioprocessing Market is valued at approximately USD 125.6 million in 2022 and is anticipated to grow with a healthy growth rate of more than ... Read More
Research Assistance
